Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of cancer and genetic disorders
3.2.1.2 Rising prevalence of infectious and chronic diseases
3.2.1.3 Growing awareness and focus on early disease detection
3.2.2 Industry pitfalls & challenges
3.2.2.1 Availability of alternative testing methods
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technological advancements
3.7 Porter’s analysis
3.8 PESTEL analysis
3.9 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Clinical biochemistry
5.3 Immunology
5.4 Haematology
5.5 Microbiology
5.6 Molecular diagnostics
5.7 Flow cytometry
5.8 Histology/Cytology
5.9 Other test types
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Oncology
6.3 Genetics
6.4 Infectious diseases
6.5 Autoimmune disorders
6.6 Neurology
6.7 Mental/behavioral disorder
6.8 Nutritional & metabolic diseases
6.9 Other applications
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital laboratories
7.3 Diagnostic centers
7.4 Clinical research organizations
7.5 Academic and research institutes
7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 23andMe, Inc.
9.2 Abbott
9.3 Bio-Rad Laboratories, Inc.
9.4 Eurofins Scientific
9.5 F. Hoffmann-La Roche Ltd.
9.6 Illumina, Inc.
9.7 NeoGenomics Laboratories
9.8 OPKO Health, Inc.
9.9 QIAGEN
9.10 Quest Diagnostics Incorporated
